No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

被引：1
|
作者：
Wagner, John E. [1 ]
Eapen, Mary [2 ]
Carter, Shelly L. [3 ]
Haut, Paul R. [4 ]
Peres, Edward [5 ]
Schultz, Kirk R. [6 ]
Thompson, Jason [3 ]
Wall, Donna A. [7 ]
Kurtzberg, Joanne [8 ]
机构：
[1] Univ Minnesota, Med Ctr, Pediat Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] EMMES Corp, Rockville, MD USA
[4] Indiana Univ, Dept Pediat, Div Hematol Oncol, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V5Z 1M9, Canada
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] Duke Univ, Med Ctr, Durham, NC USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.359.359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
359
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated on Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
    Kurtzberg, Joanne
    Carter, Shelly L.
    Mendizabal, Adam
    Wall, Donna A.
    Schultz, Kirk R.
    Kernan, Nancy A.
    Eapen, Mary
    Wagner, John E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S121 - S121
  • [2] Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants
    Kaur, Manmeet
    Horowitz, Mary M.
    Mendizabal, Adam
    Chen, Min
    Foley, Amy
    Auletta, Jeffery J.
    Devine, Steven
    D'Souza, Anita
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (01): : 49 - 57
  • [3] Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing unanswered questions
    Weisdorf, Daniel
    Carter, Shelly
    Confer, Dennis
    Ferrara, James
    Horowitz, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (03) : 257 - 262
  • [4] Comparison of Haploidentical Related Donor with Post-Transplant Cyclophosphamide (PTCy) and Umbilical Cord Blood (UCB) Transplantation after Myeloablative Conditioning for Hematological Malignancy
    Wagner, John E.
    Ballen, Karen K.
    Zhang, Mei-Jie
    Johnson, Molly H.
    Karanas, Chatchada
    Milano, Filippo
    Verneris, Michael R.
    Eapen, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S291 - S291
  • [5] PHASE II TRIAL OF NON-MYELOABLATIVE CONDITIONING (NST) DOUBLE UMBILICAL CORD BLOOD TRANSPLANTATION (DUCBT) FROM UNRELATED DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES: RESULTS OF BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL 0604
    Brunstein, C. G.
    Carter, S.
    Fuchs, E. J.
    Karanes, C.
    Devine, S.
    Aljitawi, O.
    Cutler, C.
    Ballen, K. K.
    Thompson, J.
    O'Donnell, P., V
    Eapen, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S151 - S151
  • [6] Pretransplantation Exercise and Hematopoietic Cell Transplantation Survival: A Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902)
    Wingard, John R.
    Wood, William A.
    Martens, Michael
    Le-Rademacher, Jennifer
    Logan, Brent
    Knight, Jennifer M.
    Jacobsen, Paul B.
    Jim, Heather
    Majhail, Navneet S.
    Syrjala, Karen
    Rizzo, J. Douglas
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) : 161 - 164
  • [7] Understanding Physicians' Perspectives About Translating Research Into Clinical Practice: Example of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0201 Results
    Khera, Nandita
    Mau, Lih-Wen
    Denzen, Ellen M.
    Houg, Kate
    Lee, Stephanie J.
    Horowitz, Mary M.
    Burns, Linda
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S58 - S59
  • [8] No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Compared to Conventional CBT: Results of a Randomized Trial
    Milano, Filippo
    Rezvani, Andrew R.
    Kurtzberg, Joanne
    Karanes, Chatchada
    Gutman, Jonathan A.
    Duncan, Christine
    Keyzner, Alla
    Hanna, Rabi
    Marmon, Tonya Kimberly
    Dahlberg, Ann
    Delaney, Colleen
    BLOOD, 2019, 134
  • [9] Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Kamani, Naynesh R.
    Walters, Mark C.
    Carter, Shelly
    Aquino, Victor
    Brochstein, Joel A.
    Chaudhury, Sonali
    Eapen, Mary
    Freed, Brian M.
    Grimley, Michael
    Levine, John E.
    Logan, Brent
    Moore, Theodore
    Panepinto, Julie
    Parikh, Suhag
    Pulsipher, Michael A.
    Sande, Jane
    Schultz, Kirk R.
    Spellman, Stephen
    Shenoy, Shalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) : 1265 - 1272
  • [10] Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
    Yanik, Gregory
    Ho, Vincent T.
    Horowitz, Mary
    Weisdorf, Daniel J.
    Logan, Brent R.
    Wu, Juan
    Soiffer, Robert J.
    Wingard, John R.
    Levine, John E.
    Ferrara, James L. M.
    Giralt, Sergio A.
    White, Eric
    Carter, Shelly L.
    DiFronzo, Nancy
    Cooke, Kenneth R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S169 - S169
12345